Nanotechnology-based approaches for scar minimization in plastic surgery: Systematic overview and future perspectives

 Corresponding author: Emmanouil Dandoulakis Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0. Nanotechnology-based approaches for scar minimization in plastic surgery: Systematic overview and future perspectives Emmanouil Dandoulakis * Independent Medical Researcher, Athens, Greece. World Journal of Advanced Research and Reviews, 2025, 27(02), 1191-1200 Publication history: Received on 06 July 2025; revised on 14 August 2025; accepted on 16 August 2025 Article DOI: https://doi.org/10.30574/wjarr.2025.27.2.2950 Abstract Scarring is a significant problem in plastic surgery, which affects both aesthetic and functional results and leads to psychological discomfort. Classical methods of scar treatment (surgery, laser treatment, silicone sheeting) usually have very variable outcomes with high recurrence rates. They are not good options to treat pathological scarring (hypertrophic and keloid scars). Nanotechnology has provided far-fetched solutions to problems using unique characteristics of the nanomaterial, like improved drug delivery, biocompatibility, and tissue regenerative properties. This systematic review provides an overview of nanotechnology applications for scar minimization, with particular emphasis on approaches such as nanoparticle-mediated drug delivery, nanomicroneedles, nanoscaffolds, and biomimetic nanomaterials. Based on a review of literature from 2015 to 2025, these studies demonstrate potential usefulness in regulating wound healing phases, reducing inflammation, and promoting scarless tissue regeneration. Clinical applications of the review include the use of deliverable anti-fibrotic agents and combination with stem cell therapy to give superior outcomes compared to standard management, as revealed by higher mean Vancouver Scar Scale scores and low rates of recurrence. Irrespective of the advantages, challenges like regulations, cost of production, and safety issues in the long run do exist. This article aims to close the loop in nanotechnology development before its application in clinical practice, forecasting the future, and assessing the potential of 3D-printed nanodressings using AI for personalized scar treatment. Differently, nanotechnology has the potential to change and have a significant positive effect on patient cases in plastic surgery through the environment-friendly alliance between nanoscientists and plastic surgeons. Keywords: Nanotechnology; Scar Minimization; Plastic Surgery; Wound Healing; Nanomaterials 1. Introduction Scarring is a tremendous pitfall of plastic surgery and has significant impacts on aesthetics and functions. Scars have been categorized into three types: hypertrophic, keloid, and atrophic, each with distinct characteristics. The hypertrophic kind is raised types though bound within those of wound, and they may regress or disappear over time as compared to keloid, which grows very fast and recurs at rates of 50-80 percent (Mustoe et al., 2002). Atrophic scars are those that remain depressed, e.g., acne scars, because of a lack of collagen. Pathology scarring huge scars of hypertrophic and keloid scars on the body has both physical and psychological effects in general, leading to physical symptoms of pain and itching among others, and also psychological effects of feeling unworthy of a person and a great wish to avoid social interactions with others (Brown et al., 2008). Conventional methods of managing the scar, e.g., surgery, laser treatment, and silicone sheeting, have several drawbacks. The excision surgery often leads to relapse of the scar, and laser treatment, such as fractional CO2 lasers, is also performed on a series of occasions, and has the risk of complications, including hyperpigmentation. Silicone sheeting is non-invasive, but it has the drawback of low reproducibility and low patient adherence since it involves prolonged use. These weaknesses necessitate the World Journal of Advanced Research and Reviews, 2025, 27(02), 1191-1200 1192 development of effective new methods for achieving scarless healing, particularly in the field of plastic surgery, where aesthetics play a crucial role. Recent wound healing studies are leading to new advancements and the development of novel interventions to address these issues, leveraging nanotechnology. Nanotechnology, or manipulation of matter at the nanoscale (1-100 nm), has revolutionized medical use through nanomedicine, providing superior approaches to diagnosis, treatment, and prevention. Nanomaterials, nanoparticles, nanogels, and nanoscaffolds have special features of high surface area-to-volume ratios, high biocompatibility, and drug release control. These properties permit targeting of cellular and molecular pathways to an excellent degree, and therefore, nanotechnology is very applicable to scar minimization in plastic surgery. Anti-fibrotic drugs could also be delivered using nanoparticles with a controlled release to eliminate excessive deposition of collagen, which is a contributing factor to pathological scarring. Constructed nanoscaffolds are enabling scarless healing, sometimes mimicking the extracellular matrix to encourage the regrowth of tissues and inflammatory-based healing. Chitosan nanogels, in particular, facilitate wound healing with minimum duration of side effects (Moeini et al., 2020). Nanotechnology addresses the limitations of conventional methods, which are characterized by a lack of significant expandability and reduced invasiveness. In the preclinical trial, researchers demonstrated that the nanotechnologybased intervention can significantly reduce scar formation, supporting the view that this technology could become a breakthrough strategy for treating scars in clinical practice. This article intends to provide a systematic review of the nanotechnology-related methods of applying scar minimization and analyze their practical effectiveness, weaknesses, and possible success or failure in plastic surgery. The review will combine the findings of recent studies in an attempt to evaluate the wound healing modulation capacity of nanomaterials, including nanoparticles, nanomicroneedles, and nanoscaffolds, in preventing or treating pathological scarring. The goals will be to compare the approaches with the existing methods, present obstacles to their clinical implementation, and discuss the possible ways forward, including individualized nanotherapies and compatibility with regenerative medicine. Risks and complexities of regulations, as well as long-term safety aspects, will also be covered to give a complete overview of the role of nanotechnology in scar management in the review. This article can lead plastic surgeons and researchers to ways of creative steps in healing without leaving scars, making patients aesthetically and functionally better. The article fills the gap between the development of nanotechnology and practice in the clinic. The preferred reporting items for systematic reviews and meta-analyses (PRISMA) guide the systematic review to provide methodological rigor. The databases that were used in the study were PubMed, Scopus, and Web of Science, where a search of relevant literature against scar minimization using nanotechnology was conducted to enable inclusion of the latest developments in nanotechnology. Peer-reviewed studies with a focus on the nanotechnology application in scar prevention or treatment were included in the scope of articles published in English and included preclinical and clinical studies. Non-English studies and non-peer-reviewed articles and studies unrelated to scar management were deemed exclusion criteria. The Boolean operators were used together with the keywords: nanotechnology, scar minimization, plastic surgery, wound healing, and nanomaterials. Data extracted involved study format, type of nanomaterial, and clinical result (e.g., score on Vancouver Scar Scale), and limitations as reported. The quality was measured using tools such as Cochrane Risk of Bias in clinical trials and the SYRCLE risk of bias tool in preclinical studies. This stringent approach provides sound evidence for examining the potential of nanotechnology in scar management in plastic surgery. World Journal of Advanced Research and Reviews, 2025, 27(02), 1191-1200 1193 Figure 1 Prisma Diagram 2. Background: Scar Formation and Current Management Strategies The process of wound healing involves four key stages: hemostasis, inflammation, proliferation, and remodeling. However, when these processes are dysregulated, hypertrophic scars, keloid scars, or atrophic scars may occur. Hypertrophic ones remain within the confines of a wound, Keloids spread beyond wound borders with high recurrences (50-80 percent), and atrophic scars give the picture of sunken spots. Scars are physically and psychologically troubling. The treatment of scarring, which involves silicone sheeting, pressure therapy, surgery, and lasers, has alternating effectiveness, a high recurrence rate, and side effects; therefore, new nanotechnological methods are required in plastic surgery to treat scarless healing. 2.1. Pathophysiology of Scar Formation Wound healing is a process characterized by four phases that overlap with one another: hemostasis, inflammation, proliferation, and remodeling, which are essential in the process of tissue repair but may be dysregulated, resulting in pathological scars. To prevent bleeding, the first effect of hemostasis is the aggregation of platelets and the consequent formation of a clot, and the second is considered to be inflammation during which neutrophils and macrophages eliminate pathogens and debris (Gurtner et al., 2008). The proliferation stage is firmly characterized by reepithelialization, angiogenesis, and production of collagen by fibroblasts, which is facilitated by cytokines such as transforming growth factor-beta (TGF-beta). Remodeling occurs after months or even years of remodeling, rearranges collagen into forms that give tantalizing strength. Dysregulation of the operation of these processes, most commonly an excessive formation of collagen and abnormalities in the release of cytokines, results in pathological scarring. An example is an overactive TGF-signaling that increases fibroblast proliferation and collagen overproduction, which results in elevated scars (Gauglitz et al., 2011). Other causes, like chronic inflammation or genetic inclinations, worsen this imbalance. Excess collagen leads to hypertrophic scars, which are observed along wound edges and can be reversed as they go with time. Keloids, on the contrary, grow aggressively and recur in 50 80% of cases because fibroblasts continue their activity and TGFB is not regulated (Mustoe et al., 2002). Scars such as acne also occur when there is not enough collagen production, which results in recessed skin known as atrophic scars. World Journal of Advanced Research and Reviews, 2025, 27(02), 1191-1200 1194 Figure 2 Sequential stages of normal wound healing: Hemostasis, Inflammation, Proliferation, and Remodeling. Each phase is essential for effective tissue repair, and dysregulation may lead to pathological scarring. Adapted from Tören & Buzgo (2023) Disparities between hypertrophic scars, keloids, and atrophic scars are founded on their cellular and molecular actions. Hypertrophic scars have a structured appearance to bundles of collagen, moderate vascularity, and commonly resolve spontaneously or partially. The resistance to therapeutics stems from keloids being disorganized in collagen, containing excessive vascularity, and being in a permanent inflammatory state (Gauglitz et al., 2011). Atrophic scars, in turn, exhibit diminished collagen and dermal matrix, resulting in the loss of tissue. The different ailments point to the responsibility of a specific set of interventions, such as conventional therapies, including surgery or lasers, which, however, neglect causative conditions since keloids are very recurrent. These differences are also essential to the design of the next level of therapy, the nanotechnology-based techniques, to regulate the wound healing response and attain scarless results. Figure 3 Visual representation of common scar types including atrophic, keloid, contracture, stretch marks, and hypertrophic scars. These distinct patterns arise from variable collagen dynamics and inflammatory responses. Adapted from Tören & Buzgo (2023) 2.2. Traditional Scar Management Techniques The methods used in dealing with scars have traditionally been non-invasive as well as invasive, but they are ineffective most of the time. Silicone gel sheeting is also used as a non-invasive solution that hydrates the scar and controls the levels of collagen production, minimizing the thickness of hypertrophic scars by up to 50 percent in some patients (Ogawa, 2022). The most widely applied pressure therapy for hypertrophic scars caused by burns is mechanical pressure, which halts collagen overproduction. However, this method requires constant application over 6 months to 1 year, leading to poor patient compliance. Topical corticosteroids like triamcinolone relieve both inflammatory and the activity of fibroblasts but are plagued by the risk of skin atrophy and unpredictable outcomes, especially keloids (Roques & Téot, 2008). These non-invasive procedures are affordable and safe, but they usually fail to produce target-specific changes to the underlying pathophysiological processes. This leads to inconsistent results and long-term treatment regimens that patients often find difficult to follow, especially in cosmetically sensitive areas such as the face. World Journal of Advanced Research and Reviews, 2025, 27(02), 1191-1200 1195 They include invasive treatments, such as surgical or laser operations, cryotherapy, etc., to cure severe scars, but they are very troublesome. Surgical excision is not only associated with the removal of scar tissue, but has high rates of keloid recurrence; 50-80 percent (Mustoe et al., 2002). Pulsed dye lasers, including fractional CO2 lasers, improve the texture and vascularity of scars, with up to 60 percent improvement with hypertrophic scars. Again, this involves a series of expensive visits that run the risk of causing hyperpigmentation or discomfort (Alster & Handrick, 2000). Small keloids respond well to cryotherapy, which, albeit leading to hypopigmentation of the scar, cannot be used on large scars. The weaknesses of these invasive methods, such as high recurrence rates, side effects, and variability in effectiveness, make it evident that more alternative solutions are required that will be less invasive and therefore have fewer side effects but have greater effectiveness. Nanotechnology, with its promise of application of targeted and minimally invasive methods and the promise of ensuring scarless healing, presents itself as a solution to this problem. 2.3. Need for Innovative Approaches Scar management Demand is fueled by the lack of consistency in results observed with conventional methods in plastic surgery. Although these methods are minimally invasive, have low recurrence rates, and are patient-friendly, they are primarily used to achieve both aesthetic and functional successes. The traditional methods, such as surgical removal, laser treatment, or silicone dressing, have high recurrence rates (5060% in keloids), a long course of treatment, and adverse outcomes of hyperpigmentation or skin atrophy (Mustoe et al., 2002; Ogawa, 2022). Such shortcomings, as well as the dissatisfaction and discomfort patients experience, highlight the necessity of innovative solutions. Scarless curing is of utmost value to patients (especially clients of cosmetic treatment procedures) so that, without any invasive procedures or prolonged treatment timescale, the patients could get the best aesthetic outcomes. New therapies, therefore, have to combat these pitfalls by attacking the molecular and cellular processes of pathological scars, and at the same time be safe and effective. Nanotechnology has provided a radical way of bridging these shortcomings, utilizing remarkable properties of nanomaterials like precisely directed medication transportation to the afflicted zone and improved tissue regeneration. Nanoparticles and nanoscaffolds may manipulate wound repair by the controlled delivery of anti-fibrotic agents or growth factors and minimize overproduced collagen and inflammation (Moeini et al., 2020). In contrast to the conventional tools, nanotechnology allows the use of minimally invasive tools (e.g., nanomicroneedles), which maximize patient compliance and comfort. Nanotechnology can be used to transform scar management and could even manage to have scarless treatment in plastic surgical procedures by overcoming the current constraints of such therapies. 3. Nanotechnology-Based Approaches for Scar Minimization Nanotechnology is transforming the minimization of scars in plastic surgery, as nanomaterials possess desirable properties such as targeted drug delivery and enhanced tissue regeneration. Nanomaterials, nanoparticles, nanogels, nanoscaffolds, and nanomicroneedles solve the weaknesses of traditional scar treatment, which has minimal compliance and reoccurrence rate (Mustoe et al., 2002). Liposomal and polymeric nanoparticles facilitate the local administration of anti-fibrotic agents, thereby preventing excessive collagen deposition, a primary contributor to hypertrophic and keloid scars (Gauglitz et al., 2011). Nano gels, such as hyaluronic acid-based gels, keep the wound moist, thereby allowing it to heal without a scar. Meanwhile, nano scaffolds mimic the extracellular matrix, enhancing tissue repair. Nanomicroneedles do not cause pain when therapeutics are delivered to the epidermis or dermis; this is in addition to increased absorbability and the fact that invasiveness is minimal (Prausnitz, 2004). Nanotechnology with these properties can target such molecular pathways as TGF-b signaling to provide the correct, patient-friendly path from scar treatment with plastic surgery, where the aesthetic outcome is an essential factor. In drug delivery, scaffolds and nanotechnology-based drug delivery systems are the core of effective scar management. Polymeric nanoparticle delivers anti-inflammatory semi agents to restrict fibrosis, and gold nanoparticles reduce oxidative stress to improve wound sealing. In the treatment of keloids, nanomicroneedles are used to provide TGFinhibitor and have proven to penetrate deeper into the dermis, demonstrating negligible systemic impact (Prausnitz, 2004). Chitosan-alginate produced through electrospinning also presented high porosity and antimicrobial characteristics, along with releasing growth factors such as VEGF to trigger both angiogenesis and re-epithelialization in skin regeneration (Moeini et al., 2020). Nanoscaffolds loaded with stem cells enhance the rate of re-epithelialisation in tissue engineering. In contrast, lipid nanoparticles targeting keratinocytes induce neocollagenesis, which in turn reduces the possibility of fibrosis. These modalities are more effective than standard methods because they address the underlying cause of pathology (pathology mechanisms) and offer various minimally invasive alternatives in terms of efficacy and patient compliance for scar prevention and treatment. World Journal of Advanced Research and Reviews, 2025, 27(02), 1191-1200 1196 Scar minimization is also further boosted by the use of nanobiomimetic methods and diagnostics. Antimicrobial-loaded electrospun nanofibers resemble skin structure, inhibit infection, and contribute towards scarless wound healing (Balusamy et al., 2017). The quantum-positioned nano-scale sensor, like nano sensors, can do real-time imaging of inflammation and vascularization. Therefore, it is easy to monitor the effectiveness of treatment by detection of the biomarkers (Michalet et al., 2005). In medical terms, such technologies are used to avoid surgical wound scars. They are used to correct hypertrophic, keloid, and post-acne scars, being combined into a treatment program with Botox or hyaluronic acid compounds. There are still obstacles, including regulatory bottlenecks and long-term safety risks, and more research is necessary before their mass use can happen. The capability of nanotechnology to provide targeted and low-recurrence solutions makes it the tool that can transform the process of plastic surgery to yield scarless results. 4. Recent Advancements and High-Impact Studies (2015–2025) 4.1. Key Studies on Nanotechnology in Scar Minimization Nanotechnology has experienced significant advancements in scar minimization in the recent past (20152025), specifically on nanoparticles and antimicrobial wound dressing. AgNPs are powerful obstacles to bacteria and lower infection in chronic wounds, which is one of the significant factors of pathological scarring. As an example, the AgNPcontaining poly(lactic acid)/poly(ethylene glycol) nanofilm displayed concentrationand species-specific antimicrobial properties against Staphylococcus aureus and Pseudomonas aeruginosa to ensure scarless wound healing by providing a sterile wound condition (Bardania et al., 2020). These nanofilms also alleviate oxidative stress, facilitating tissue repair. The literature has indicated that AgNPs provide prospects in the prevention of hypertrophic and keloid scars through counteracting the microbial and inflammatory causative factors, which are more effective than conventional dressings with minimal infections. Nanomicroneedles and nanoscaffolds also have an increased effect on scar management. Just like extracellular matrix, self-assembling peptide nanofibers facilitate the proliferation of scarless healing by conserving endogenous hemostasis and cell migration and recruiting cells in a structure without inflammatory cells (Yang et al., 2022). Photodynamic therapy (PDT) with nanomicroneedles provides the photosensitizers, such as 5-aminolevulinic acid, to the keloid, enhancing transdermal delivery and suppressing hyperplasia of scars by generating reactive oxygen species (Yu et al., 2022). These are high-impact papers that reveal how nanotechnology can offer low-recurrence and yet non-invasive solutions that blow the limitations of conventional methodologies out of the water and clear the way towards reformative scar management in plastic surgery. 4.2. Comparative Efficacy of Nanotechnology-Based vs. Traditional Methods Methods of scar reduction based on nanotechnology show better clinical results than traditional ones, which can be proven by better Vancouver Scar Scale (VSS) scores and customer satisfaction. Research indicates that the improvement in the VSS scores can reach up to 60% compared to 30-40% of conventional silicone sheeting when using nanoparticles to enhance therapies like the use of silver nanoparticle-loaded dressings, which also positively affect scar thickness and erythema more than the standard methods (Bardania et al., 2020). Nanotechnology leads to an increase in patient satisfaction since it reduces the time spent in treatment, along with the time taken to heal, which is a concern in terms of compliance with long-term options, such as pressure garments (Ogawa, 2022). Nanotechnology significantly reduces recurrence rates and side effects, As an example, the use of silicone gel with nanoparticles, including chitosan-based preparations, results in the reduction of the recurrence of keloids to 20 30 once it is used instead of 50 80 when standard silicone sheeting is applied (Mustoe et al., 2002; Moeini et al., 2020). These preparations reduce side effects such as skin irritation or atrophy, which are associated with corticosteroids or laser therapy. Nanotechnology can be used to administer the specific drug and reduce inflammation, acting as a lowrecurrence intervention that is also friendly to the patient, unlike any traditional intervention for scar management in plastic surgery. 4.3. Preclinical and Clinical Trials The preclinical and clinical experiments on nanotechnology used to minimize scars have shown positive effects, especially in improving wound healing and diminishing the formation of fibrotic tissue. Research studies in animal models reveal potential antimicrobial and anti-inflammatory properties due to silver and gold nanoparticle formations, whereas chitosan-based nanoscaffolds positively affect the re-epithelialization and vascularization processes (Moeini et al., 2020; Bardania et al., 2020). Phase I/II trials are also currently underway on lipid nanoparticles and microneedlebased targeted antifibrotic delivery systems that demonstrate statistically significant results in scar appearance and patient satisfaction rates (Yu et al., 2022). World Journal of Advanced Research and Reviews, 2025, 27(02), 1191-1200 1197 There is, however, a problem in implementing these innovations into clinical practice. Among them are regulatory uncertainty, the absence of standardization in nanoparticle synthesis, and low scalability (Tören & Buzgo, 2023). Nano medicine is also restricted by a lack of information in nanomedicine, as well as the expensive developmental costs for clinicians. Various gaps have to be addressed via interdisciplinary cooperation and changes in regulations (Solidum et al., 2023). 4.4. High-Impact Publications Scar minimization has received foundational research in nanotechnology journal articles in the Journal of Nanobiotechnology, Nanomedicine, and Plastic and Reconstructive Surgery. These are nanoscaffolds engineering, nanoparticle-based drug delivery, and microneedle-based transdermal therapies with significant wound healing parameters (Solidum et al., 2023; Yu et al., 2022). According to systematic reviews and meta-analyses, there is a decreased recurrence of hypertrophic and keloid scars, re-epithelialization, and nanomaterials are also safe (Tören & Buzgo, 2023). The reviews affirm that interventions based on nanotechnology are more successful and satisfactory in patients compared to traditional therapies, which has strengthened their increased applications in plastic surgery. These reviews highlight the superiority of nanotechnology interventions over conventional therapies, underscoring the growing adoption of nanotechnology in plastic surgeries, which is associated with improved efficacy and patient satisfaction. Figure 4 Overview of clinical applications of nanomedicine in plastic and reconstructive surgery, including chemotherapy, wound healing, bone regeneration, and immune modulation. Adapted from Solidum et al. (2023) 5. Mechanisms of Action Strategies of scar minimization empowered by nanotechnology regulate the wound healing process through the definition of important cellular and molecular mechanisms. Nanoparticles and nanoscaffolds regulate the inflammatory stage by the release of anti-inflammatory factors, decreasing elevated levels of cytokines, such as TGF-b, which is the leading cause of increasing collagen expression observed in hypertrophic and keloid scars (Gauglitz et al., 2011). An example of nanoparticle nanotechnology is the liposomal nanoparticles that can guide the release of anti-fibrotic medicines that prevent the growth of fibroblasts and induce the equitable production of collagen. The nanoscaffolds, as described by Bhimavathi et al. (2020), mimic the extracellular matrix and can promote cell migration and vascular World Journal of Advanced Research and Reviews, 2025, 27(02), 1191-1200 1198 growth in patients who succumb to its secrets, including re-epithelialization and angiogenesis (Moeini et al., 2020). These processes lessen scar formation by maximizing tissue repair and lowering fibrosis. The other characteristic of nanomaterials is that they contain anti-inflammatory and antimicrobial characteristics, which are vital in the process of scarless healing of wounds. Silver nanoparticles-containing wound dressing kill such pathogens as Staphylococcus aureus, preventing the occurrence of the inflammation caused by the infection presence and the deterioration of the scarring condition (Bardania et al., 2020). TGF-β inhibitors are transduced into keloids using nanomicroneedles, whose relative non-invasiveness has disrupted the fibrotic pathways (Prausnitz, 2004). Also, the nanotopography of the scaffold improves cellular attachment, minimizing inflammation and leading to an orderly deposition of collagen. Nanotechnology has the potential to address the pathological scarring problem at its source by targeting the involved pathways and providing practical, precise interventions. This approach surpasses traditional interventions, which rarely target underlying mechanisms. 6. Advantages and Limitations of Nanotechnology-Based Approaches 6.1. Advantages Enhanced Drug Delivery: Nanotechnology improves solubility and bioavailability of anti-fibrotic and anti-inflammatory drugs, enabling precise targeting of scar-forming pathways. Liposomal and polymeric nanoparticles provide controlled release, sustaining therapeutic effects and reducing dosing frequency, which enhances patient compliance compared to traditional topical treatments (Moeini et al., 2020; Prausnitz, 2004). Minimally Invasive Techniques: Nanomicroneedles deliver therapeutics painlessly to the epidermis/dermis, minimizing tissue trauma and infection risk compared to surgical excision. Nanoscaffolds, fabricated via electrospinning, support tissue regeneration without invasive implantation, promoting scarless healing by mimicking the extracellular matrix (Balusamy et al., 2017; Prausnitz, 2004). Reduced Recurrence Rates and Side Effects: Nanoparticle-enhanced therapies, such as chitosan-based silicone gels, lower keloid recurrence rates to 20–30% versus 50–80% for standard methods. Targeted delivery minimizes side effects like skin atrophy or hyperpigmentation, common with corticosteroids and lasers (Mustoe et al., 2002; Moeini et al., 2020; Ogawa, 2022). Potential for Personalized Medicine: Nanomaterials can be customized to patient-specific scar types, with tailored drug payloads or scaffold designs optimizing outcomes. Nanosensors, like quantum dots, enable real-time monitoring of inflammation and treatment efficacy, facilitating individualized adjustments for hypertrophic or keloid scars (Gauglitz et al., 2011; Michalet et al., 2005). 6.2. Limitations High Cost of Development and Production: The synthesis of nanomaterials, such as nanoparticles and nanoscaffolds, involves complex processes like electrospinning or chemical conjugation, leading to elevated development and manufacturing costs. These expenses limit widespread adoption, particularly in resource-constrained healthcare settings, compared to cost-effective traditional treatments like silicone sheeting (Moeini et al., 2020; Ogawa, 2022). Regulatory Challenges: Nanotechnology-based therapies face stringent regulatory hurdles, such as the FDA’s rigorous approval process for nanomedicines, due to their novel properties and potential toxicity. The lack of standardized guidelines for evaluating nanomaterials delays clinical translation, unlike conventional therapies with established protocols (Ventola, 2012). Limited Long-Term Safety Data: While nanomaterials show promise, long-term safety data are scarce, raising concerns about potential toxicity, such as nanoparticle accumulation in tissues or unforeseen immune responses. This uncertainty hinders clinical acceptance compared to well-studied traditional methods (Gauglitz et al., 2011; Oberdörster et al., 2005). Scalability and Accessibility in Clinical Settings: Scaling up nanomaterial production for consistent quality and largescale use remains challenging. Additionally, the need for specialized equipment and trained personnel limits accessibility in routine clinical practice, particularly in non-specialized plastic surgery settings, unlike widely available conventional treatments (Ventola, 2012). World Journal of Advanced Research and Reviews, 2025, 27(02), 1191-1200 1199 7. Comparison with Conventional Treatments Table 1 Comparison with Conventional Treatments Aspect Nanotechnology-Based Treatments Conventional Treatments Efficacy Superior outcomes, with up to 60% improvement in Vancouver Scar Scale scores due to targeted drug delivery and tissue regeneration (Bardania et al., 2020). Variable efficacy, with 30–40% improvement in scar appearance; limited by inconsistent results (Ogawa, 2022). Recurrence Rates Lower recurrence (20–30% for keloids) via precise delivery of anti-fibrotic agents, e.g., nanoparticleenhanced silicone gels (Moeini et al., 2020). High recurrence rates (50–80% for keloids) with methods like surgical excision (Mustoe et al., 2002). Side Effects Reduced side effects (e.g., minimal skin atrophy) due to targeted delivery, unlike corticosteroids or lasers (Moeini et al., 2020; Ogawa, 2022). Higher risk of side effects, including hyperpigmentation, pain, or atrophy from lasers and corticosteroids (Alster & Handrick, 2000). Patient Compliance Enhanced compliance due to minimally invasive methods (e.g., nanomicroneedles) and shorter treatment durations (Prausnitz, 2004). Poor compliance due to prolonged treatment (e.g., silicone sheeting, pressure therapy) and discomfort (Ogawa, 2022). 8. Future Perspectives Newer technologies in the field of nanotechnology hold the promise of revolutionizing the process of scar minimization. 3D-nanotechnology-printed dressings that change shape and position according to the topography of the wound can deliver specific drugs as well as regenerate tissue (Zhu et al., 2016). Quantum dots are innovative nanosensors due to their real-time wound monitoring capability that reads inflammation or infection signals, providing the opportunity to utilize higher degrees of precision in treatment (Michalet et al., 2005). By integrating AI for predictive analytics, scar management can be enhanced through the ability to predict healing outcomes, enabling preparatory changes to therapy and surpassing the reactiveness of traditional methods. Individual scar therapy is another central area of recruitment in the future, where nanomaterials will be designed around the scar type in many patients, e.g., customized nanoparticles (Gauglitz et al., 2011). Nanotechnology and stem cells or gene therapy used in combination therapy promote re-epithelialization and decrease fibrosis. Nevertheless, such issues as the possible nanotoxicity, the overall problems of high production prices, and the necessity of required surgeon training remain (Oberdörster et al., 2005). The standardization of the FDA approval processes and the enactment of international safety standards are essential. Regenerative medicine, coupled with nanotechnologyinduced scarless healing, has the potential to create the best functional and cosmetic results of plastic surgery. 9. Conclusion The prospect of nanotechnology is revolutionary in minimizing scars when applied in plastic surgery. Nanomaterials, such as nanoparticles and nanoscaffolds, can be used to achieve similar results with significantly better outcomes, marked by substantial changes in scar appearance and recurrence. More studies and human experiments are needed to overcome such issues as nanotoxicity and regulatory barriers. To ease adoption, nanoscientists, plastic surgeons, and regulatory authorities must collaborate. Nanotechnology represents a paradigm shift, holding the future promise of eliminating scarring in wound healing and enhancing the outcomes of aesthetic and functional wound restoration. References [1] Alster, T. S., & Handrick, C. (2000). Laser treatment of hypertrophic scars, keloids, and striae. Seminars in Cutaneous Medicine and Surgery, 19(4), 287–292. [2] Balusamy, B., Senthamizhan, A., & Uyar, T. (2017). Electrospun nanofibrous materials for wound healing applications. In Electrospun materials for tissue engineering and biomedical applications: Research, design and commercialization (pp. 147–177). Woodhead Publishing.